AMENDED - Standard Form TR-1
Voting rights attached to shares- Article 12(1) of directive 2004/109/EC
Financial instruments - Article 11(3) of the Commission Directive 2007/14/EC i
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: |
Ryanair Holdings plc |
2. Reason for the notification (please tick the appropriate box or boxes |
||
|
an acquisition or disposal of voting rights |
|
|
an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|
an event changing the breakdown of voting rights |
|
x |
Other: |
This filing is being made to reflect the direct holdings of the individual mutual fund under the management of Capital Research and Management Company ("CRMC"). Please note that the mutual fund has delegated its voting rights to CRMC. |
3. Full name of person(s) subject to the notification obligationiii: |
Europacific Growth Fund ("EUPAC") |
4. Full name of shareholder(s) (if different from the person mentioned in point 3.)iv: |
|
5. Date of the transaction and date on which the threshold is crossed or reachedv: |
1 January 2010 |
6. Date on which issuer is notified: |
4 January 2010 |
7. Threshold(s) that is/are crossed or reached: |
Above 3% |
8. Notified details:
A) Voting rights attached to shares |
|||||||
Class/type of shares (if possible using the ISIN CODE) |
Situation previous to the Triggering transactionvi |
Resulting situation after the triggering transactionvii |
|||||
Number of Sharesviii |
Number of Voting rightsix |
Number of sharesx |
Number of voting rights xi |
% of voting rights |
|||
Direct |
Direct xii |
Indirect xiii |
Direct |
Indirect |
|||
ADRs US7835131043 |
19,373,900 |
96,869,500 |
19,373,900 |
96,869,500 |
|
6.5573% |
|
|
|
|
|
|
|
|
|
SUBTOTAL A (based on aggregate voting rights) |
19,373,900 |
96,869,500 |
19,373,900 |
96,869,500 |
6.5573% |
B) Financial Instruments |
||||
Resulting situation after the triggering transaction xiv |
||||
Type of financial instrument |
Expiration Date xv |
Exercise/Conversion Period/ Date xvi |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
N/A |
|
|
|
|
|
|
|
|
|
|
SUBTOTAL B (in relation to all expiration dates) |
|
|
Total (A+B) [where applicable in accordance with national law] |
number of voting rights |
% of voting rights |
70,269,500 |
70,269,500 |
4.7567% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable xvii: |
n/a |
10. In case of proxy voting: [name of the proxy holder] will cease to hold [number] voting rights as of [date]. |
n/a |
11. Additional information: |
This filing is being made to reflect EUPAC's direct ownership in shares as previously reported to you in Schedule A in a report made on behalf of Capital Research and Management Company, the fund's investment adviser on 8 January 2009. This filing does not reflect an acquisition or disposition of shares, but rather it reflects a clarification of direct ownership. |
Done at Los Angeles, California on 4 January 2010
c) Additional information